| Property | Value |
| Working Groups | AG E. Zeisberg, AG Hasenfuß |
| Subproject | D01 |
| Open Access | Yes |
| Publication Type | Journal Article |
| Peer Reviewed | Yes |
| PMID | 42117551 |
| DOI | 10.1093/eschf/xvag083 |
| Publication Year | 2026 |
| Title | Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: Design and rationale of the Reduce-MFA DZHK25 trial |
| Journal | ESC Heart Failure |
| ISSN | 2055-5822 |
| eISSN | 2055-5822 |
| URL | https://doi.org/10.1093/eschf/xvag083 |
| Journal Abbreviation | ESC Heart Fail |
| Authors | Puls M, Zeisberg EM, Placzek M, Beuthner BE, Jacob CF, Steinhaus KE, Lange T, Tostmann R, Schnelle M, Schuster A, Hasenfuß G, Friede T |
| First Author | Puls M |
| Last Author | Friede T |
External Resources
gro-2/177472http://resolver.sub.uni-goettingen.de/purl?gro-2/177472
GRO.publications identifier
031t5w623https://ror.org/031t5w623
ROR identifier (031t5w623, German Centre for Cardiovascular Research)
021ft0n22https://ror.org/021ft0n22
ROR identifier (021ft0n22, University Medical Center Göttingen)